Financial Strength
-
Abbott Announces 409th Consecutive Quarterly Dividend
Abbott Laboratories declared its 409th consecutive quarterly dividend, showcasing over a century of consistent financial strength and dedication to shareholders. This enduring payout reflects a robust healthcare portfolio across medical devices, diagnostics, nutrition, and pharmaceuticals, supported by innovation and market leadership. Abbott’s dividend policy signals confidence in its business model and sustained profitability, making it a reliable investment and a key indicator in the healthcare sector.
-
Westamerica Bancorporation Launches Share Buyback Program
Westamerica Bancorporation’s Board of Directors has authorized a new stock repurchase program to buy back up to 2,000,000 shares of common stock by December 31, 2026. This move, representing approximately 8.0% of outstanding shares, reflects the bank’s strong financial position and commitment to enhancing shareholder value through a prudent use of capital. The buybacks will be discretionary, executed based on market conditions.
